Dr. Chitnis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
60 Fenwood Road, 1B
Neurology
Boston, MA 02115Phone+1 617-525-6550Fax+1 617-525-6554
Education & Training
Drexel University College of Medicine/Hahnemann University HospitalResidency, Neurology, 1995 - 1998
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 1994 - 1995
University of Toronto Faculty of MedicineClass of 1994
Certifications & Licensure
MA State Medical License 1999 - 2026
NH State Medical License 2023 - 2025
ME State Medical License 2021 - 2024
RI State Medical License 2021 - 2024
PA State Medical License 1995 - 1998
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis Start of enrollment: 2011 Oct 01
- Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS Start of enrollment: 2015 May 01
Publications & Presentations
PubMed
- Endocrine disrupting chemicals in early MS disease activity.Tzu-Ying Chuang, Brenna A LaBarre, Osman Corbali, Brian C Healy, Shrishti Saxena
Journal of Neuroimmunology. 2025-03-15 - Limited early IVIG for the treatment of pediatric myelin oligodendrocyte glycoprotein antibody-associated disease.Rebecca MacRae, Jonathan Race, Allison Schuette, Michael Waltz, Theron Charles Casper
Multiple Sclerosis and Related Disorders. 2025-03-10 - Association Between Sun Exposure and Risk of Relapse in Pediatric-Onset Multiple Sclerosis.Gina Chang, Prince Sebastian, Akash Virupakshaiah, Vinicius A Schoeps, Nicolas Cherbuin
Neurology(R) Neuroimmunology & Neuroinflammation. 2025-03-01
Journal Articles
- Autologous Hematopoietic Stem Cell Transplant in Multiple SclerosisTanuja Chitnis, Nancy L Sicotte, JAMA Neurology
- Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple SclerosisJerry S Wolinsky, Lauren Krupp, Emmanuelle Waubant, Tanuja Chitnis, Brenda Banwell, Kevin Rostasy, The New England Journal of Medicine
Press Mentions
New Immune Biomarkers Uncovered with Foralumab TreatmentJanuary 29th, 2025- Tiziana Life Sciences Announces Discovery of New Immune Biomarkers in Multiple Sclerosis Patients Treated with Nasal ForalumabJanuary 22nd, 2025
- 2024-2026 James T. Lubin Fellowship Award Recipients AnnouncedDecember 19th, 2024
- Join now to see all
Committees
- Board Member, ACTRIMS - Americas Committee for Treatment and Research in MS 2020 - Present
- Board Member, National Multiple Sclerosis Clinical Advisory Committee 2019 - Present
- Chair, International Pediatric Multiple Sclerosis Study Group (IPMSSG) 2010 - 2018
Professional Memberships
- Member
Other Languages
- French, Marathi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
